PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years
• Thyroidectomy or bilateral thyroid resection of any indication
• Written informed consent obtained after detailed patient information and provision of an information sheet
Locations
Other Locations
Germany
Dept. Surgery I; University Hospital Wuerzburg
RECRUITING
Würzburg
Contact Information
Primary
Nicolas Schlegel, Prof. Dr. (MD)
SCHLEGEL_N@ukw.de
+49 931 201 38217
Backup
Nicole Kirschbauer, Study Nurse
kirschbauer_n@ukw.de
+49 931 201 31173
Time Frame
Start Date: 2025-01-08
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 336
Treatments
Sham_comparator: Standard of Care
Measurement of parathormone levels and calcium on postoperative day 1 (beginning at day 1 after surgery)
Experimental: Early postoperative sampling of parathyroid hormone and Calcium (within 1-3 hours after surgery))
Measurement of parahthyroid hormone and calcium within 1-3 hours post surgery
Related Therapeutic Areas
Sponsors
Leads: Nicolas Schlegel
Collaborators: University of Wuerzburg